NRO Stock Overview
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally.
No risks detected for NRO from our risk checks.
Price History & Performance
|Historical stock prices|
|Current Share Price||€39.35|
|52 Week High||€39.55|
|52 Week Low||€30.20|
|1 Month Change||14.06%|
|3 Month Change||8.25%|
|1 Year Change||24.13%|
|3 Year Change||83.88%|
|5 Year Change||40.59%|
|Change since IPO||354.91%|
Recent News & Updates
Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year
Neurones S.A. ( EPA:NRO ) has announced it will be reducing its dividend payable on the 10th of June to €1.00. However...
|NRO||FR IT||FR Market|
Return vs Industry: NRO exceeded the French IT industry which returned -17.2% over the past year.
Return vs Market: NRO exceeded the French Market which returned -6.4% over the past year.
|NRO Average Weekly Movement||3.1%|
|IT Industry Average Movement||4.7%|
|Market Average Movement||4.9%|
|10% most volatile stocks in FR Market||9.1%|
|10% least volatile stocks in FR Market||2.9%|
Stable Share Price: NRO is less volatile than 75% of French stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: NRO's weekly volatility (3%) has been stable over the past year.
About the Company
|1984||5,869||Luc de Chammard||https://www.neurones.net|
Neurones S.A., an information technology (IT) services company, provides infrastructure, application, and consulting services in France and internationally. Its infrastructure services include infrastructure management, clouds, user support, DevOps, cybersecurity, IT service management, information system governance, and automation. The company also provides application services in the areas of SAP integration and outsourcing; mobility, data, IoT, digital, agile, UX/UI, and DevOps; IT consulting for finance, big data, AI and blockchain; content management, business process management, paperless process; and IT training and working with change management.
Neurones Fundamentals Summary
|NRO fundamental statistics|
Is NRO overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NRO income statement (TTM)|
|Cost of Revenue||€323.30m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Sep 07, 2022
|Earnings per share (EPS)||1.56|
|Net Profit Margin||6.50%|
How did NRO perform over the long term?See historical performance and comparison
2.5%Current Dividend Yield
Is NRO undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NRO?
Other financial metrics that can be useful for relative valuation.
|What is NRO's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does NRO's PE Ratio compare to its peers?
|NRO PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
AUB Aubay Société Anonyme
SWP Sword Group
Price-To-Earnings vs Peers: NRO is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the peer average (20.1x).
Price to Earnings Ratio vs Industry
How does NRO's PE Ratio compare vs other companies in the FR IT Industry?
Price-To-Earnings vs Industry: NRO is expensive based on its Price-To-Earnings Ratio (25.3x) compared to the French IT industry average (22.1x)
Price to Earnings Ratio vs Fair Ratio
What is NRO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||25.3x|
|Fair PE Ratio||26.2x|
Price-To-Earnings vs Fair Ratio: NRO is good value based on its Price-To-Earnings Ratio (25.3x) compared to the estimated Fair Price-To-Earnings Ratio (26.2x).
Share Price vs Fair Value
What is the Fair Price of NRO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NRO (€39.35) is trading below our estimate of fair value (€70.06)
Significantly Below Fair Value: NRO is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
How is Neurones forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Future Growth Score3/6
Future Growth Score 3/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NRO's forecast earnings growth (12.9% per year) is above the savings rate (0.3%).
Earnings vs Market: NRO's earnings (12.9% per year) are forecast to grow faster than the French market (11.5% per year).
High Growth Earnings: NRO's earnings are forecast to grow, but not significantly.
Revenue vs Market: NRO's revenue (7.8% per year) is forecast to grow faster than the French market (5.2% per year).
High Growth Revenue: NRO's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NRO's Return on Equity is forecast to be low in 3 years time (15.1%).
Discover growth companies
How has Neurones performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NRO has high quality earnings.
Growing Profit Margin: NRO's current net profit margins (6.5%) are higher than last year (5.9%).
Past Earnings Growth Analysis
Earnings Trend: NRO's earnings have grown by 6.9% per year over the past 5 years.
Accelerating Growth: NRO's earnings growth over the past year (22%) exceeds its 5-year average (6.9% per year).
Earnings vs Industry: NRO earnings growth over the past year (22%) underperformed the IT industry 31.7%.
Return on Equity
High ROE: NRO's Return on Equity (12.2%) is considered low.
Discover strong past performing companies
How is Neurones's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: NRO's short term assets (€464.1M) exceed its short term liabilities (€184.6M).
Long Term Liabilities: NRO's short term assets (€464.1M) exceed its long term liabilities (€30.3M).
Debt to Equity History and Analysis
Debt Level: NRO has more cash than its total debt.
Reducing Debt: NRO's debt to equity ratio has reduced from 1.1% to 0.1% over the past 5 years.
Debt Coverage: NRO's debt is well covered by operating cash flow (15769.7%).
Interest Coverage: NRO earns more interest than it pays, so coverage of interest payments is not a concern.
Discover healthy companies
What is Neurones's current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NRO's dividend (2.54%) is higher than the bottom 25% of dividend payers in the French market (1.68%).
High Dividend: NRO's dividend (2.54%) is low compared to the top 25% of dividend payers in the French market (5.25%).
Stability and Growth of Payments
Stable Dividend: NRO's dividends per share have been stable in the past 10 years.
Growing Dividend: NRO's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (64.2%), NRO's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (41.8%), NRO's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Luc de Chammard (68 yo)
Mr. Luc de Chammard serves as the Chairman, Chief Executive Officer and Chief Information Officer of Neurones S.A. and served as its Co-Chief Executive Officer. Mr. de Chammard has been a Director at Neuro...
CEO Compensation Analysis
Compensation vs Market: Luc's total compensation ($USD225.57K) is below average for companies of similar size in the French market ($USD610.54K).
Compensation vs Earnings: Luc's compensation has been consistent with company performance over the past year.
Experienced Board: NRO's board of directors are seasoned and experienced ( 17.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Neurones S.A.'s employee growth, exchange listings and data sources
- Name: Neurones S.A.
- Ticker: NRO
- Exchange: ENXTPA
- Founded: 1984
- Industry: IT Consulting and Other Services
- Sector: Software
- Implied Market Cap: €953.234m
- Shares outstanding: 24.22m
- Website: https://www.neurones.net
Number of Employees
- Neurones S.A.
- Immeuble “le Clemenceau 1”
- 205, Avenue Georges
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/14 00:00|
|End of Day Share Price||2022/08/12 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.